Customised Assays and Disease Modelling

Customised Assays and Disease Modelling Services

Invitrocue has established expertise in customised human primary cell-based assays (both 2D and 3D) to support late stage compound evaluation for lead optimization/candidate selection.

  • Repeated dose toxicity
  • Repeated dose DMPK
  • Modeling infectious disease in vitro
    • Hepatitis B
    • Hepatitis C
    • Malaria liver stage
  • Model development for non-alcoholic steatosis hepatitis (NASH)
  • Idiosyncratic toxicity in vitro
  • Mechanistic understanding of benign ALT increase
  • Wound healing models